EXOKĒRYX

EXOKĒRYX is a United States-based biotechnology company headquartered in San Diego, California. With a team of 11 employees, the company generates $2.5 million in annual revenue. EXOKĒRYX develops and provides advanced technology tools for researchers focused on Extracellular Vesicles (EVs). Their products and services aim to simplify and accelerate the study of EVs, which play a crucial role in inter-cellular communication and hold significant potential for early disease detection, diagnosis, and therapy development. The company's technology centers around semiconductor-based chip-like platforms utilizing dielectrophresis to isolate EVs with high recovery and purity. EXOKĒRYX believes that decoding EV biomarkers will revolutionize disease detection, allowing for earlier identification of cancers and other illnesses. For more information about EXOKĒRYX and its groundbreaking technologies, visit their website at exokeryx.com.